Hologic Completes the Acquisition of Gen-Probe

By LabMedica International staff writers
Posted on 06 Aug 2012

Hologic (Bedford, MA, USA) has completed the acquisition of Gen-Probe (San Diego, CA, USA) for a net purchase price of USD 3.72 billion.

Gen-Probe is a molecular diagnostics company with services used to diagnose human diseases, screen donated human blood, ensure transplant compatibility, and aid biomedical research.

The acquisition will allow Hologic to expand its growing diagnostics products and services business. Hologic, Inc. is a developer, manufacturer, and supplier of diagnostic products, medical imaging systems, and surgical products. The company operates four core business units focused on breast health, diagnostics, GYN surgical, and skeletal health.

“Gen-Probe is an ideal partner and strategic fit to Hologic’s existing diagnostics business and complements our focus on scaling and diversifying our diagnostics franchise,” Robert A. Cascella, the chief executive of Hologic, said in a statement. “Our combined company will be well positioned globally to capitalize on the fast-growing molecular diagnostics market with an established global infrastructure.”

Related Links:
Hologic
Gen-Probe